These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27814879)

  • 21. Commentary on "early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: Results of a match-controlled multi-institutional analysis". Briganti A, Wiegel T, Joniau S, Cozzarini C, Bianchi M, Sun M, Tombal B, Haustermans K, Budiharto T, Hinkelbein W, Di Muzio N, Karakiewicz PI, Montorsi F, Van Poppel H., Department of Urology, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy: Eur Urol 2012;62:472-87. Epub;2012, May 16.
    Smith JA
    Urol Oncol; 2012; 30(6):960. PubMed ID: 23218078
    [No Abstract]   [Full Text] [Related]  

  • 22. Erratum for the Research Article: "Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance" by W. Roh, P.-L. Chen, A. Reuben, C. N. Spencer, P. A. Prieto, J. P. Miller, V. Gopalakrishnan, F. Wang, Z. A. Cooper, S. M. Reddy, C. Gumbs, L. Little, Q. Chang, W.-S.Chen, K. Wani, M. P. De Macedo, E. Chen, J. L. Austin-Breneman, H. Jiang, J. Roszik, M. T. Tetzlaff, M. A. Davies, J. E. Gershenwald, H. Tawbi, A. J. Lazar, P. Hwu, W.-J. Hwu, A. Diab, I. C. Glitza, S. P. Patel, S. E. Woodman, R. N. Amaria, V. G. Prieto, J. Hu, P. Sharma, J. P. Allison, L. Chin, J. Zhang, J. A. Wargo, P. A. Futreal.
    Sci Transl Med; 2017 Apr; 9(385):. PubMed ID: 28404861
    [No Abstract]   [Full Text] [Related]  

  • 23. R.A. Q. O'Meara, D.SC., M.D., F.R.C.P.I., D.P.H.
    Br Med J; 1975 Feb; 1(5954):402. PubMed ID: 1090334
    [No Abstract]   [Full Text] [Related]  

  • 24. [The correlation between the level of prostate-specific antigen and prostate gland volume in the early diagnosis of prostatic cancer].
    Billebaud T; Astier L; Villers A; Boccon-Gibod L; Dauge MC; Sibert A; Baron JC; Delmas V; Boccon-Gibod L
    Prog Urol; 1991 Feb; 1(1):124-31. PubMed ID: 1285391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium.
    Ornstein DK; Englert C; Gillespie JW; Paweletz CP; Linehan WM; Emmert-Buck MR; Petricoin EF
    Clin Cancer Res; 2000 Feb; 6(2):353-6. PubMed ID: 10690510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: the prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. C. G. Roehrborn, S. N. Gange, N. D. Shore, J. L. Giddens, D. M. Bolton, B. E. Cowan, B. T. Brown, K. T. McVary, A. E. Te, S. S. Gholami, P. Rashid, W. G. Moseley, P. T. Chin, W. T. Dowling, S. J. Freedman, P. F. Incze, K. S. Coffield, F. D. Borges and D. B. Rukstalis J Urol 2013;190:2161-2167.
    Gupta S; Singh V; Goel A
    J Urol; 2014 Jun; 191(6):1934-5. PubMed ID: 25405255
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: the prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. C. G. Roehrborn, S. N. Gange, N. D. Shore, J. L. Giddens, D. M. Bolton, B. E. Cowan, B. T. Brown, K. T. McVary, A. E. Te, S. S. Gholami, P. Rashid, W. G. Moseley, P. T. Chin, W. T. Dowling, S. J. Freedman, P. F. Incze, K. S. Coffield, F. D. Borges and D. B. Rukstalis J Urol 2013;190:2161-2167.
    Mavuduru RS; Devana SK; Nayak B
    J Urol; 2014 Jun; 191(6):1934. PubMed ID: 24631348
    [No Abstract]   [Full Text] [Related]  

  • 28. Commentary on "locally advanced prostate cancer: a population-based study of treatment patterns". W.T. Lowrance, E.B. Elkin, D.S. Yee, A. Feifer, B. Ehdaie, L.M. Jacks, C.L. Atoria, M.J. Zelefsky, H.I. Scher, P.T. Scardino, J.A. Eastham, Department of Surgery, Division of Urology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA: BJU Int. 2012; 109(9):1309-14. doi: 10.1111/j.1464-410X.2011.10760.x. Epub 2011 Nov 15.
    Smith JA
    Urol Oncol; 2012; 30(6):961-2. PubMed ID: 23218079
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostate Cancer: Diffusion-weighted MR Imaging for Detection and Assessment of Aggressiveness-Comparison between Conventional and Kurtosis Models.
    Tamada T; Prabhu V; Li J; Babb JS; Taneja SS; Rosenkrantz AB
    Radiology; 2017 Jul; 284(1):100-108. PubMed ID: 28394755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LITERATURE ABSTRACTS.
    J Texture Stud; 1971 Dec; 2(4):502-509. PubMed ID: 28370130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Protocol for the Early vs. Late Infantile Strabismus Surgery Study.
    Simonsz H
    Strabismus; 1993; 1(3):135-57. PubMed ID: 21314554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commentary on: "Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES study." Escudier B, Porta C, Bono P, Powles T, Eisen T, Sternberg CN, Gschwend JE, De Giorgi U, Parikh O, Hawkins R, Sevin E, Négrier S, Khan S, Diaz J, Redhu S, Mehmud F, Cella D. Bernard Escudier, Institut Gustave Roussy, Villejuif; Emmanuel Sevin, Centre François Baclesse, Caen; Sylvie Négrier, Leon Berard Cancer Center, Lyon, France; Camillo Porta, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico S. Matteo, Pavia; Cora N Sternberg, San Camillo Forlanini Hospital, Rome; Ugo De Giorgi, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy; Petri Bono, Helsinki University Central Hospital, Helsinki, Finland; Thomas Powles, Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London; Tim Eisen, Cambridge University Health Partners, Cambridge; Omi Parikh, Royal Preston Hospital, Lancashire; Robert Hawkins, Christie Cancer Research UK, Manchester; Sadya Khan, Jose Diaz, and Faisal Mehmud, GlaxoSmithKline, Uxbridge, United Kingdom; Jürgen E Gschwend, Klinikum Rechts der Isar der Technischen Universität München, Munich, Germany; Suman Redhu, GlaxoSmithKline, Collegeville, PA; David Cella, Northwestern University Feinberg School of Medicine, Chicago, IL.: J Clin Oncol. 2014 May 10;32(14):1412-1418; doi: 10.1200/JCO.2013.50.8267. [Epub 2014 Mar 31].
    Trump D
    Urol Oncol; 2016 May; 34(5):251. PubMed ID: 25937427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.
    Morton RA; Ewing CM; Nagafuchi A; Tsukita S; Isaacs WB
    Cancer Res; 1993 Aug; 53(15):3585-90. PubMed ID: 8339265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical evaluation of an MR-compatible microwave ablation system and comparison with a standard microwave ablation system in an ex vivo bovine liver model.
    Hoffmann R; Kessler DE; Weiss J; Clasen S; Pereira PL; Nikolaou K; Rempp H
    Int J Hyperthermia; 2017 Sep; 33(6):617-623. PubMed ID: 28110576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes: W. T. Lowrance, E. B. Elkin, L. M. Jacks, D. S. Yee, T. L. Jang, V. P. Laudone, B. D. Guillonneau, P. T. Scardino and J. A. Eastham J Urol 2010; 183: 1366-1372.
    See WA
    J Urol; 2010 Oct; 184(4):1573-4; author reply 1574. PubMed ID: 20732691
    [No Abstract]   [Full Text] [Related]  

  • 36. The trouble with Martin O'Meara.
    Martyr P; Davison S
    Australas Psychiatry; 2015 Oct; 23(5):536-9. PubMed ID: 26229054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Permanent prostate brachytherapy preplanned technique: The modern Seattle method step-by-step and dosimetric outcomes.
    Sylvester JE; Grimm PD; Eulau SM; Takamiya RK; Naidoo D
    Brachytherapy; 2009; 8(2):197-206. PubMed ID: 19433321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erratum for the Report "A precise measurement of the magnetic field in the corona of the black hole binary V404 Cygni" by Y. Dallilar, S. S. Eikenberry, A. Garner, R. D. Stelter, A. Gottlieb, P. Gandhi, P. Casella, V. S. Dhillon, T. R. Marsh, S. P. Littlefair, L. Hardy, R. Fender, K. Mooley, D. J. Walton, F. Fuerst, M. Bachetti, A. J. Castro-Tirado, M. Charcos, M. L. Edwards, N. M. Lasso-Cabrera, A. Marin-Franch, S. N. Raines, K. Ackley, J. G. Bennett, A. J. Cenarro, B. Chinn, H. V. Donoso, R. Frommeyer, K. Hanna, M. D. Herlevich, J. Julian, P. Miller, S. Mullin, C. H. Murphey, C. Packham, F. Varosi, C. Vega, C. Warner, A. N. Ramaprakash, M. Burse, S. Punnadi, P. Chordia, A. Gerarts, H. de Paz Martín, M. Martín Calero, R. Scarpa, S. Fernandez Acosta, W. M. Hernández Sánchez, B. Siegel, F. Francisco Pérez, H. D. Viera Martín, J. A. Rodríguez Losada, A. Nuñez, Á. Tejero, C. E. Martín González, C. Cabrera Rodríguez, J. Molgó, J. Esteban Rodriguez, J. I. Fernández Cáceres, L. A. Rodríguez García, M. Huertas Lopez, R. Dominguez, T. Gaggstatter, A. Cabrera Lavers, S. Geier, P. Pessev, A. Sarajedini.
    Science; 2018 Apr; 360(6386):. PubMed ID: 29674566
    [No Abstract]   [Full Text] [Related]  

  • 39. Commentary on "Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer." Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, Hamstra DA, Shipley WU, Hahn SM, Zietman AL, Bekelman JE, Efstathiou JA. Harvard Radiation Oncology Program, Boston, MA.: Cancer 2013;119(9):1729-35. doi: 10.1002/cncr.27956. [Epub 2013 Feb 22].
    Gottschalk A
    Urol Oncol; 2014 Apr; 32(3):373-4. PubMed ID: 24679463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commentary on: "Comprehensive transcriptional analysis of early-stage urothelial carcinoma." Hedegaard J, Lamy P, Nordentoft I, Algaba F, Høyer S, Ulhøi BP, Vang S, Reinert T, Hermann GG, Mogensen K, Thomsen MB, Nielsen MM, Marquez M, Segersten U, Aine M, Höglund M, Birkenkamp-Demtröder K, Fristrup N, Borre M, Hartmann A, Stöhr R, Wach S, Keck B, Seitz AK, Nawroth R, Maurer T, Tulic C, Simic T, Junker K, Horstmann M, Harving N, Petersen AC, Calle ML, Steyerberg EW, Beukers W, van Kessel KE, Jensen JB, Pedersen JS, Malmström PU, Malats N, Real FX, Zwarthoff EC, Ørntoft TF, Dyrskjøt L. Cancer Cell. 2016 Jul 11;30(1):27-42.
    Lee BH
    Urol Oncol; 2017 Sep; 35(9):576-577. PubMed ID: 28789929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.